MYC and hepatocellular carcinoma: USP33 can also stabilise the mutant p53 protein (Figure S2), and p53 gain‐of‐function mutant (p53‐R249S) has been shown to drive PLC/PRF/5 HCC cell proliferation and tumorigenesis by stabilising c‐myc [22, 23].